28/10/2025
🔬 “The next era builds on this foundation, uniting inflammation science, biomarkers, and precision medicine to personalize care.”
Dr. Pramod K. Mistry of Yale School of Medicine shares his vision for the future of Gaucher disease treatment — from breakthrough enzyme therapies to precision medicine and lifelong patient impact.